Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by Calimmune, Inc.
Sponsor:
Information provided by (Responsible Party):
Calimmune, Inc.
ClinicalTrials.gov Identifier:
NCT01734850
First received: November 19, 2012
Last updated: June 18, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)